Insulin resistance in heart failure: Differences between patients with reduced and preserved left ventricular ejection fraction

European Journal of Heart Failure

Volumn 17, Issue 10, 2015, Pages 1015-1021

  Scherbakov, Nadja ^a,b   Bauer, Maximiliane ^a   Sandek, Anja ^a   Szabõ, Tibor ^a   Töpper, Agnieszka ^c,d   Jankowska, Ewa A ^e,f   Springer, Jochen ^g   Von Haehling, Stephan ^f   Anker, Stefan D ^f   Lainscak, Mitja ^h   Engeli, Stefan ⁱ   Düngen, Hans Dirk ^a   Doehner, Wolfram ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d HELIOS KLINIKUM BERLIN BUCH   (Germany)

^e MILITARY HOSPITAL   (Poland)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h General and Teaching Hospital Celje   (Slovenia)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

DEXA; HFpEF; HFrEF; HOMA; Insulin resistance; Short insulin sensitivity test

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN DERIVATIVE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEDICAL PARAMETERS; PRESERVED HEART LEFT VENTRICLE EJECTION FRACTION; PRIORITY JOURNAL; REDUCED HEART LEFT VENTRICLE EJECTION FRACTION; REFERENCE VALUE; SHORT INSULIN SENSITIVITY TEST; STEADY STATE; ANALYSIS; BLOOD; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; BLOOD GLUCOSE; FEMALE; HEART FAILURE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84946478746     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.317     Document Type: Article

References (28)

1. Greenfield M, Kolterman O, Olefsky J, Reaven GM,. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 1980; 18: 441-446.
2. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD,. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005; 46: 1019-1026.
3. Doehner W, Rauchhaus M, Godsland IF, Egerer K, Niebauer J, Sharma R, Cicoira M, Florea VG, Coats AJ, Anker SD,. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol 2002; 83: 73-81.
4. Wisniacki N, Taylor W, Lye M, Wilding JP,. Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure. Heart 2005; 91: 32-37.
5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
6. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJ,. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997; 30: 527-532.
7. Patel HC, Hayward C, di Mario C, Cowie MR, Lyon AR, Rosen SD,. Heart failure with preserved ejection fraction: the impact of stricter definitions. Eur J Heart Fail 2014; 16: 767-771.
8. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M,. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-378.
9. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira M, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJ,. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999; 20: 683-693.
10. Doehner W, Frenneaux M, Anker SD,. Metabolic impairment in heart failure: the myocardial and systemic perspective. J Am Coll Cardiol 2014; 64: 1388-1400.
11. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP,. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-1007.
12. Sabelis LW, Senden PJ, Zonderland ML, van de Wiel A, Wielders JP, Huisveld IA, van Haeften TW, Mosterd WL,. Determinants of insulin sensitivity in chronic heart failure. Eur J Heart Fail 2003; 5: 759-765.
13. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K,. Uncoupling proteins in human heart. Lancet 2004; 364: 1786-1788.
14. Doehner W, Gathercole D, Cicoira M, Krack A, Coats AJ, Camici PG, Anker SD,. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol 2010; 138: 19-24.
15. Sverrisdõttir YB, Jansson LM, Hägg U, Gan L-M,. Muscle sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy individuals. PLoS One 2010; 5:e9257.
16. Gjedsted J, Buhl M, Nielsen S, Schmitz O, Vestergaard ET, Tønnesen E, Møller N,. Effects of adrenaline on lactate, glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg. Acta Physiol (Oxf) 2011; 202: 641-648.
17. Verloop WL, Beeftink MM, Santema BT, Bots ML, Blankestijn PJ, Cramer MJ, Doevendans PA, Voskuil M,. A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction. PLoS One 2015; 10:e0117332.
18. Millar PJ, Murai H, Floras JS,. Paradoxical muscle sympathetic reflex activation in human heart failure. Circulation 2015; 131: 459-468.
19. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP,. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150.
20. Parsonage W, Hetmanski D, Cowley A,. Differentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failure. Am J Cardiol 2002; 89: 696-703.
21. Dyck DJ, Heigenhauser GJ, Bruce CR,. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006; 186: 5-16.
22. Szabõ T, Scherbakov N, Sandek A, Kung T, von Haehling S, Lainscak M, Jankowska EA, Rudovich N, Anker SD, Frystyk J, Flyvbjerg A, Pfeiffer AF, Doehner W,. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. Nutr Metab Cardiovasc Dis 2014; 24: 50-56.
23. Szabõ T, Postrach E, Mähler A, Kung T, Turhan G, von Haehling S, Anker SD, Boschmann M, Doehner W,. Increased catabolic activity in adipose tissue of patients with chronic heart failure. Eur J Heart Fail 2013; 15: 1131-1137.
24. Birkenfeld AL, Adams F, Schroeder C, Engeli S, Jordan J,. Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition. Hypertension 2011; 57: e4-e5.
25. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H,. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-748.
26. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J,. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005; 90: 3622-3628.
27. Lainscak M, Keber I, Anker SD,. Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol 2006; 106: 319-322.
28. Kovacic D, Marinsek M, Gobec L, Lainscak M, Podbregar M,. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. Clin Res Cardiol 2008; 97: 24-31.